Assignee
TARVEDA THERAPEUTICS INC
US·8 granted patents·29 pending applications·13 citations·filing 2014–2021
Top patents by PatentIndex Score
37 records- 0187US9750818B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·6 cites·2 claims
- 0286US10624967B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·8 claims
- 0382US10322191B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·5 claims
- 0480US10548881B2HSP90 targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 4, 2020·1 cites·32 claims
- 0579US11241500B2HSP90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 8, 2022·1 cites·19 claims
- 0676US2020121808A1Sstr-targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0764US2022096640A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0863US2022096646A1Sstr-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0963US2020339990A1RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOFTARVEDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1063US2022054647A1Sstr-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1162US2016166715A1Nanoparticle Diagnostic and Methods for Treating DiseaseTARVEDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1261US9480657B2Cabazitaxel-platinum nanoparticles and methods of using sameTARVEDA THERAPEUTICS INC·Filed 2014·Granted Nov 1, 2016·0 cites·13 claims
- 1361US2019231906A1Nanoparticle diagnostic and methods for treating diseaseTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1459US2018021454A1Targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1556US11160871B2SSTR-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Nov 2, 2021·0 cites·10 claims
- 1655US2020230126A1Targeted therapeuticsTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1752US2021145971A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1851US11213590B2SSTR-targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jan 4, 2022·0 cites·10 claims
- 1951US2018273948A1RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOFTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2051US2022184217A1Hsp90-binding conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2149US2021186978A1Combination therapyTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2249US2022031853A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2349US2021169871A1Pharmaceutical compositions with reduced tert-butanol levelsTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2448US2020237746A1Hsp90 targeted conjugates and particle formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2546US2020230247A1Combination therapies comprising targeted therapeuticsTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2645US2019365913A1Stapled peptide conjugates and particlesTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2745US2020009262A1Targeted constructs and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2843US2018296685A1Targeted constructs and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2943US2018221503A1Compositions and methods for immuno-oncology therapiesTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3043US2020078468A1Neurotensin receptor binding conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3142US2018258411A1Compositions and methods for genome editingTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3241US2019085034A1Antibody mimic conjugates and particlesTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3341US2021000966A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3441US2019125888A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3541US2020281934A1Sstr-targeted conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3640US2018221508A1Compositions and methods for immunomodulationTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3738US2017151339A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TARVEDA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →